Supplementary Table S3 from Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma

MLA

Yi-Long Wu, et al. Supplementary Table S3 from Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22462068.v1.

APA

Yi-Long Wu, Si-Pei Wu, Ri-Qiang Liao, Li-Xu Yan, Hao-Ran Zhai, Hong-Hong Yan, Jia-Xin Lin, Xue-Ning Yang, Jin-Ji Yang, Qing Zhou, Yue-Li Sun, Hua-Jun Chen, Hai-Yan Tu, Si-Yang Liu, Zhi Xie, Jian Su, Xu-Chao Zhang, Wen-Zhao Zhong, & Zhong-Yi Dong. (2023). Supplementary Table S3 from Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma. https://doi.org/10.1158/1078-0432.22462068.v1

Chicago

Yi-Long Wu, Si-Pei Wu, Ri-Qiang Liao, Li-Xu Yan, Hao-Ran Zhai, Hong-Hong Yan, Jia-Xin Lin, et al. 2023. “Supplementary Table S3 from Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma,” March. doi:10.1158/1078-0432.22462068.v1.